The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device
Open accessAbstract
Three-dimensional (3D) tumor spheroid possesses great potential as an in vitro model to improve predictive capacity for pre-clinical drug testing. In this paper, we combine advantages of flow cytometry and microfluidics to perform drug testing and analysis on a large number (5000) of uniform sized tumor spheroids. The spheroids are formed, cultured and treated with drugs inside a microfluidic device. The spheroids can then be harvested from the device without tedious operation. Due to the ample cell numbers, the spheroids can be dissociated into single cells for flow cytometry analysis. Flow cytometry provides statistical information in single cell resolution that makes it feasible to better investigate drug functions on the cells in more in vivo-like 3D formation. In the experiments, human hepatocellular carcinoma cells (HepG2) are exploited to form tumor spheroids within the microfluidic device and three anti-cancer drugs: Cisplatin, Resveratrol and Tirapazamine (TPZ) and their combinations are tested on the tumor spheroids with two different sizes. The experimental results suggest the cell culture format (2D monolayer vs. 3D spheroid) and spheroid size play critical roles in drug responses and also demonstrate the advantages of bridging the two techniques in pharmaceutical drug screening applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surprisingly, even when treating spheroids with a relative high drug concentration, only 30% (or fewer) tumor cells died in 3D spheroid drug testing.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The spheroids in 2D cultures were significantly more susceptible to cisplatin.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cisplatin had its highest apoptotic activity in small spheroids.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They rebuilt largely in vitro 3D tumor tissues and were able to generate a hypoxic environment in the inner core, which greatly recapitulated in vivo spatial oxygen distribution.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [215]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the cell culture format (two-dimensional monolayer versus three-dimensional spheroid) and spheroid size play key roles in drug responses and show the advantages of connecting these two technologies in drug screening applications.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [178]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Boyd, M. R., & Paull, K. D. (1995) · Drug Development Research · doi:10.1002/ddr.430340203 · Cited by 1,572
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
Tung, Y.-C., Hsiao, A. Y., Allen, S. G., Torisawa, Y.-S., Ho, M., & Takayama, S. (2011) · The Analyst · doi:10.1039/c0an00609b · Cited by 969
Self-citationBarry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797
The biological lifetime of nitric oxide: Implications for the perivascular dynamics of NO and O 2
Thomas, D. D., Liu, X., Kantrow, S. P., & Lancaster, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.355 · Cited by 760
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Cited by
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages
Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212200 · Cited by 547
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
“In fact, a recent two-layered microfluidic device was developed that allowed the formation, culture, and drug testing of 5000 uniform-sized tumor spheroids with different culture chamber geometries (200 × 200 μm2 and 300 × 300 μm2) [68].”
MethodOrganoid and Spheroid Tumor Models: Techniques and Applications
Gunti, S., Hoke, A. T. K., Vu, K. P., & London, N. R. (2021) · Cancers · doi:10.3390/cancers13040874 · Cited by 479
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Hydrogel microenvironments for cancer spheroid growth and drug screening
Li, Y., & Kumacheva, E. (2018) · Science Advances · doi:10.1126/sciadv.aas8998 · Cited by 351
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
Moshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
“In fact, several previous works have suggested that 2D-monolayer cell cultures should be replaced with multicellular tumor spheroids that better recapitulate the in-vivo environment [5-9].”
BackgroundMethodInfluentialTumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Amaral, R. L. F., Miranda, M., Marcato, P. D., & Swiech, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00605 · Cited by 222
“…researchers choose to work with spheroids of diameter ranging between 300 and 500 µm Frontiers in Physiology | www.frontiersin.org 8 August 2017 | Volume 8 | Article 605 (Friedrich et al., 2009; Hardelauf et al., 2011; Wen et al., 2013; Ivanov et al., 2014; Patra et al., 2016;Wan et al., 2016).”
MethodMicrofluidic platforms for cell cultures and investigations
Coluccio, M. L., Perozziello, G., Malara, N., Parrotta, E., Zhang, P., Gentile, F., Limongi, T., Raj, P. M., Cuda, G., Candeloro, P., et al. (2019) · Microelectronic Engineering · doi:10.1016/j.mee.2019.01.004 · Cited by 198
“In addition, microscopic and macroscopic image acquisition systems are also employed for accuracy and precision data [57,117,127].”
MethodTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Multiscale cytometry and regulation of 3D cell cultures on a chip
Sart, S., Tomasi, R. F.-X., Amselem, G., & Baroud, C. N. (2017) · Nature Communications · doi:10.1038/s41467-017-00475-x · Cited by 174
Review and perspectives on microfluidic flow cytometers
Yang, R., Fu, L., & Hou, H.-H. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.03.091 · Cited by 142
Millard, M., Yakavets, I., Zorin, V. P., Kulmukhamedova, A., Marchal, S., & Bezdetnaya, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146927 · Cited by 149
“36,42 Recently, Patra et al demonstrated the advantage to couple microfluidics with flow cytometry for the rapid production and viability analysis of a great number of MCTS with well-defined size, which were submitted to different drugs and their combination.”
Methods of Delivering Mechanical Stimuli to Organ-on-a-Chip
Kaarj, K., & Yoon, J. (2019) · Micromachines · doi:10.3390/mi10100700 · Cited by 153
“Instead of syringes, the PDMS chip was placed on the computer-controlled tilting stage to drive the flow within the chip where the co-culture of liver (HepG2) and cancer (HeLa) cells existed and used to observe the pharmacokinetic and pharmacodynamic of anti-cancer drug activities (Figure 5B) [55].”
Mulholland, T., McAllister, M. J., Patek, S., Flint, D., Underwood, M., Sim, A., Edwards, J., & Zagnoni, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33055-0 · Cited by 139
Decarli, M. C., do Amaral, R. L. F., dos Santos, D. P., Tofani, L. B., Katayama, E. T., Rezende, R. A., da Silva, J. V. L., Swiech, K., Suazo, C. A. T., Mota, C., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abe6f2 · Cited by 153
“When using the annexin V-FITC-PI conjugated method, subpopulations of healthy cells can be quantified (both annexin V and PI negative), as well as apoptotic cells (annexin V positive and PI negative) and dead cells (both annexin V and PI positive) [188, 194].”
An end-user perspective on Organ-on-a-Chip: Assays and usability aspects
Junaid, A., Mashaghi, A., Hankemeier, T., & Vulto, P. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.02.002 · Cited by 133
Advances in Spheroids and Organoids on a Chip
Fang, G., Chen, Y., Lu, H., & Jin, D. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202215043 · Cited by 141
A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems
Chen, Y., Gao, D., Wang, Y., Lin, S., & Jiang, Y. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.06.038 · Cited by 128
Nayak, P., Bentivoglio, V., Varani, M., & Signore, A. (2023) · Cancers · doi:10.3390/cancers15194846 · Cited by 134
From 2D to 3D Cancer Cell Models—The Enigmas of Drug Delivery Research
Zundert, I. V., Fortuni, B., & Rocha, S. (2020) · Nanomaterials · doi:10.3390/nano10112236 · Cited by 133
Anticancer drug discovery using multicellular tumor spheroid models
Zanoni, M., Pignatta, S., Arienti, C., Bonafè, M., & Tesei, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1570129 · Cited by 117
Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs
Santo, V. E., Rebelo, S. P., Estrada, M. F., Alves, P. M., Boghaert, E. R., & Brito, C. (2016) · Biotechnology Journal · doi:10.1002/biot.201600505 · Cited by 118
Thomsen, A. R., Aldrian, C. J., Bronsert, P., Thomann, Y., Nanko, N., Mélin, N., Rücker, G., Follo, M., Grosu, A., Niedermann, G., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00832e · Cited by 99
Sabhachandani, P., Sarkar, S., McKenney, S., Ravi, D., Evens, A. M., & Konry, T. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.010 · Cited by 90
In vitromicrofluidic models of tumor microenvironment to screen transport of drugs and nanoparticles
Özçelikkale, A., Moon, H., Linnes, M. P., & Han, B. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1460 · Cited by 94
Dhiman, N., Kingshott, P., Sümer, H., Sharma, C. S., & Rath, S. N. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.02.070 · Cited by 90
Rodenhizer, D., Dean, T., D'Arcangelo, E., & McGuigan, A. P. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701174 · Cited by 80
Recent Advances in Three-Dimensional Multicellular Spheroid Culture and Future Development
Shen, H., Cai, S., Wu, C., Yang, W., Yu, H., & Liu, L. (2021) · Micromachines · doi:10.3390/mi12010096 · Cited by 89
Three-Dimensional Cell Culture and Drug Testing in a Microfluidic Sidewall-Attached Droplet Array
Zhao, S.-P., Ma, Y., Lou, Q., Zhu, H., Yang, B., & Fang, Q. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02267 · Cited by 71
The impact of microfluidics in high-throughput drug-screening applications
Stefano, P. D., Bianchi, E., & Dubini, G. (2022) · Biomicrofluidics · doi:10.1063/5.0087294 · Cited by 82
Behroodi, E., Latifi, H., Bagheri, Z., Ermis, E., Roshani, S., & Moghaddam, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-79015-5 · Cited by 82
Gutzweiler, L., Kartmann, S., Tröndle, K., Benning, L., Finkenzeller, G., Zengerle, R., Koltay, P., Stark, G. B., & Zimmermann, S. (2017) · Biofabrication · doi:10.1088/1758-5090/aa7218 · Cited by 71
Pozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 79
Emerging tumor-on-chips with electrochemical biosensors
Lei, L., Ma, B., Xu, C., & Liu, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116640 · Cited by 72
Edmondson, R., Adcock, A. F., & Yang, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158116 · Cited by 76
“This is consistent with the observations in previous studies which have shown that larger spheroids often exhibit increased resistance to treatment [51, 52].”
ResultFibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Lee, S. W., Kwak, H. S., Kang, M.-H., Park, Y.-Y., & Jeong, G. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-20886-0 · Cited by 68
Advanced technological tools to study multidrug resistance in cancer
Andrei, L., Kasas, S., Ochoa, I., Stanković, T., Korsnes, M. S., Václavíková, R., Assaraf, Y. G., & Pešić, M. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100658 · Cited by 74
“Therefore, several microfluidic devices were developed to investigate the effect of different cell/spheroid size on drug susceptibility (Pang et al., 2016; Patra et al., 2016; Zuchowska et al., 2017).”
BackgroundMethodResultMulti-size spheroid formation using microfluidic funnels
Marimuthu, M., Rousset, N., St‐Georges‐Robillard, A., Lateef, M. A., Ferland, M., Mes‐Masson, A., & Gervais, T. (2017) · Lab on a Chip · doi:10.1039/c7lc00970d · Cited by 71
Organ-on-a-Chip Applications in Microfluidic Platforms
An, L., Liu, Y., & Liu, Y. (2025) · Micromachines · doi:10.3390/mi16020201 · Cited by 78
“Furthermore, OoCs exhibit significant potential in investigating tumor aggressiveness, identifying new therapeutic targets, and assessing pharmacological effectiveness and toxicity [124,125].”
Adverse (geno)toxic effects of bisphenol A and its analogues in hepatic 3D cell model
Sendra, M., Štampar, M., Fras, K., Novoa, B., Figueras, A. J., & Žegura, B. (2022) · Environment International · doi:10.1016/j.envint.2022.107721 · Cited by 58
Gonzales‐Aloy, E., Ahmed-Cox, A., Tsoli, M., Ziegler, D. S., & Kavallaris, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114777 · Cited by 61
Mun, S. G., Choi, H. W., Lee, J. M., Lim, J. H., Ha, J. H., Kang, M., Kim, E.-J., Kang, L., & Chung, B. G. (2020) · Nano Convergence · doi:10.1186/s40580-020-0220-3 · Cited by 57
Żuchowska, A., Kwapiszewska, K., Chudy, M., Dybko, A., & Brzózka, Z. (2017) · Electrophoresis · doi:10.1002/elps.201600417 · Cited by 58
Shrirao, A. B., Fritz, Z., Novik, E., Yarmush, G., Schloss, R. S., Zahn, J. D., & Yarmush, M. L. (2018) · TECHNOLOGY · doi:10.1142/s2339547818300019 · Cited by 62
Clamping strategies for organ-on-a-chip devices
Carvalho, D. J., Moroni, L., & Giselbrecht, S. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00523-z · Cited by 52
Järvinen, P. P., Bonabi, A., Jokinen, V. P., & Sikanen, T. M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000479 · Cited by 55
An integrated cell printing system for the construction of heterogeneous tissue models
Liu, T., Pang, Y., Zhou, Z., Yao, R., & Sun, W. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.052 · Cited by 50
Khot, M. I., Levenstein, M. A., de Boer, G., Armstrong, G., Maisey, T. I., Svavarsdottir, H. S., Andrew, H., Perry, S., Kapur, N., & Jayne, D. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-72952-1 · Cited by 48
Zhang, Z., Chen, L., Wang, Y., Zhang, T., Chen, Y., & Yoon, E. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03896 · Cited by 46
Foglizzo, V., Cocco, E., & Marchiò, S. (2022) · Cancers · doi:10.3390/cancers14153692 · Cited by 51
3D tumor spheroids: morphological alterations a yardstick to anti-cancer drug response
Senrung, A., Lalwani, S., Janjua, D., Tripathi, T., Kaur, J., Ghuratia, N., Aggarwal, N., Chhokar, A., Yadav, J., Chaudhary, A., et al. (2023) · In vitro models · doi:10.1007/s44164-023-00059-8 · Cited by 50
“Microfluidic cell culture chamber size of 200 × 200 μm 2 generated spheroids of human hepatocellular carcinoma cells (HepG2) with an average diameter of 130.5 μm while the larger chamber of 300 × 300 μm 2 generated spheroids with average diameter of 212.7 μm [57].”
BackgroundMethodInfluentialEvaluating Nanoparticles in Preclinical Research Using Microfluidic Systems
Zhu, D., Long, Q., Xu, Y., & Xing, J. (2019) · Micromachines · doi:10.3390/mi10060414 · Cited by 42
Rousset, N., Monet, F., & Gervais, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-00229-1 · Cited by 42
Engineered in vitro tumor models for cell-based immunotherapy
Ando, Y., Mariano, C. F., & Shen, K. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.076 · Cited by 39
Microfluidic-Based Single-Cell Study: Current Status and Future Perspective
Wu, H., Zhu, J., Huang, Y., Wu, D., & Sun, J. (2018) · Molecules · doi:10.3390/molecules23092347 · Cited by 34
“Three anticancer drugs were applied to tumor spheroids, and microfluidic FC were utilized to provide post-treated information in single cell resolution, which made it easier to compare the drug functions on tumor cells in more in vivo-like 3D situation [97].”
MethodHercog, K., Štampar, M., Štern, A., Filipič, M., & Žegura, B. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114965 · Cited by 36
Barisam, M., Saidi, M. H., Kashaninejad, N., Vadivelu, R. K., & Nguyen, N. (2017) · Micromachines · doi:10.3390/mi8120358 · Cited by 37
Blood–Labyrinth Barrier in Health and Diseases: Effect of Hormetic Nutrients
Cosentino, A., Agafonova, A., Modafferi, S., Salinaro, A. T., Scuto, M. C., Maiolino, L., Fritsch, T., Calabrese, E. J., Lupo, G., Anfuso, C. D., et al. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0251 · Cited by 38
“…in polyphenols including curcumin, resveratrol, sulforaphane, epigallocatechin gallate, and olive oil extracts highlighting the critical advantages of using 3D cell culture format rather than the traditional monolayer cultures (Barros et al., 2018; Esposito et al., 2022; Patra et al., 2016).”
Time-resolved non-invasive metabolomic monitoring of a single cancer spheroid by microfluidic NMR
Patra, B., Sharma, M., Hale, W. G., & Utz, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79693-1 · Cited by 34
Self-citationAhmed-Cox, A., Pandžić, E., Johnston, S. T., Heu, C., McGhee, J. B., Mansfeld, F. M., Crampin, E. J., Davis, T. P., Whan, R. M., & Kavallaris, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.014 · Cited by 39
Patra, B., Lafontaine, J., Bavoux, M., Zerouali, K., Glory, A., Ahanj, M., Carrier, J., Gervais, T., & Wong, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-38666-9 · Cited by 34
Self-citationWu, Y., Zhou, Y., Qin, X., & Liu, Y. (2021) · Biomicrofluidics · doi:10.1063/5.0062697 · Cited by 33
Organ-on-Chip platforms to study tumor evolution and chemosensitivity
Dsouza, V. L., Kuthethur, R., Kabekkodu, S. P., & Chakrabarty, S. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188717 · Cited by 38
Pirone, D., Lu, X., Bianco, V., Miccio, L., Xiao, W., Che, L., Li, X., Memmolo, P., Pan, F., & Ferraro, P. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132963 · Cited by 31
Pitingolo, G., Nizard, P., Riaud, A., & Taly, V. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.07.166 · Cited by 35
Tan, Z., Xie, S., Hu, S.-Y., Liao, T., Liu, P., Peng, K.-H., Yang, X., He, Z., Tang, H., Yuan, C., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3662 · Cited by 30
Caring for cells in microsystems: principles and practices of cell-safe device design and operation
Varma, S., & Joel Voldman, B. (2018) · Lab on a Chip · doi:10.1039/c8lc00746b · Cited by 31
Sarkar, S., Peng, C., & Tung, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240833 · Cited by 33
“, Newton, MA) on silicon wafers by conventional photolithography, followed by silanization in a desiccator to prevent undesired bonding [59].”
BackgroundMethodSelf-citationLei, K. F., Lin, B.-Y., & Tsang, N. (2017) · RSC Advances · doi:10.1039/c7ra00209b · Cited by 32
“21 These drug e ffi ciency analyses o en require additional processing and sophisticated instrumentation, which makes high throughput screening infeasible.”
BackgroundOwen, H. C., Appiah, S. S., Hasan, N., Ghali, L. R., Elayat, G., & Bell, C. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.012 · Cited by 27
HepG2 spheroids as a biosensor-like cell-based system for (geno)toxicity assessment
Štampar, M., Žabkar, S., Filipič, M., & Žegura, B. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.132805 · Cited by 26
Kheiri, S., Kumacheva, E., & Young, E. W. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.781566 · Cited by 30
Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
Patra, B., Lateef, M. A., Brodeur, M. N., Fleury, H., Carmona, E., Péant, B., Provencher, D. M., Mes‐Masson, A., & Gervais, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244549 · Cited by 31
“The PDMS microfluidic device used in this work is a modification of a previously described device [35].”
MethodSelf-citationMoradian, C., & Rahbarizadeh, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-93972-5 · Cited by 26
Microfluidic Droplet-Assisted Fabrication of Vessel-Supported Tumors for Preclinical Drug Discovery
Wu, Y., Zhao, Y., Zhou, Y., Islam, K., & Liu, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c23305 · Cited by 26
Novel biomarkers in cancer: The whole is greater than the sum of its parts
Samatov, T. R., Galatenko, V., Block, A., Shkurnikov, M. Y., Tonevitsky, A., & Schumacher, U. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.09.002 · Cited by 27
Collagen-Laponite Nanoclay Hydrogels for Tumor Spheroid Growth
Alamán‐Díez, P., Borau, C., Guerrero, P. E., Amaveda, H., Mora, M., Fraile, J. M., García‐Gareta, E., García‐Aznar, J. M., & Pérez, M. Á. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00257 · Cited by 25
The Applications and Challenges of the Development of In Vitro Tumor Microenvironment Chips
Johnson, A., Reimer, S., Childres, R., Cupp, G., Kohs, T. C. L., McCarty, O. J. T., & Kang, Y. B. (2022) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-022-00755-7 · Cited by 26
Deep learning unlocks label-free viability assessment of cancer spheroids in microfluidics
Chiang, C., Anne, R., Chawla, P. A., Shaw, R. M., He, S., Rock, E. C., Zhou, M., Cheng, J., Gong, Y., & Chen, Y. (2024) · Lab on a Chip · doi:10.1039/d4lc00197d · Cited by 27
Multicellular Human Gastric Cancer Spheroids Mimic the Glycosylation Phenotype of Gastric Carcinomas
Balmaña, M., Mereiter, S., Diniz, F., Feijão, T., Barrias, C. C., & Reis, C. A. (2018) · Molecules · doi:10.3390/molecules23112815 · Cited by 24
“In this regard, microfluidic platforms that allow the formation of a thousand MCTS within a chip have been recently reported [6,7].”
BackgroundTechnological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Bērziņa, S., Harrison, A., Taly, V., & Xiao, W. (2021) · Cancers · doi:10.3390/cancers13164192 · Cited by 29
“In closed-format tumor-on-chip systems, the reversal of the flow direction or increase in flow rates is typically used for spheroid recovery [10,85].”
BackgroundInfluentialRousset, N., López-Sandoval, R., Modena, M. M., Hierlemann, A. R., & Misun, P. M. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00348-w · Cited by 24
Zhao, P., Wang, J., Chen, C., Wang, J., Liu, G., Nandakumar, K., Li, Y., & Wang, L. (2022) · Micromachines · doi:10.3390/mi13020200 · Cited by 27
“The effects of three anticancer drugs on tumor spheroids were studied [95].”
BackgroundAzizipour, N., Avazpour, R., Weber, M. H., Sawan, M., Ajji, A., & Rosenzweig, D. H. (2022) · Micromachines · doi:10.3390/mi13040587 · Cited by 27
“) also play a critical role in regulating cell responses to the surfaces [32,33].”
BackgroundBioartificial livers: a review of their design and manufacture
Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6e86 · Cited by 24
“Moreover, microwell arrays can be fabricated in microfluidic devices using micropattern technique to trap cells and generate uniformly sized spheroids, providing an effective platform for high-throughput biochemical analysis and drug screening [143–145].”
Microfluidic technologies to engineer mesenchymal stem cell aggregates—applications and benefits
Salehi, S. S., Shamloo, A., & Hannani, S. K. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00613-8 · Cited by 24
“Organoid-on-a-chip and body-on-achip are new technologies to monitor the kinetics of tumor progression and metastasis in vitro (Skardal et al., 2016; Porto et al., 2016; Jackson and Lu, 2016,Marsano et al., 2016; Ashammakhi et al., 2018).”
MethodPipiya, V. V., Gilazieva, Z. E., Issa, S. S., Rizvanov, A. A., & Solovyeva, V. V. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00237 · Cited by 23
Krivitsky, V., Zverzhinetsky, M., Krivitsky, A., Hsiung, L.-C., Naddaka, V. I., Gabriel, I., Lefler, S., Conroy, J., Burstein, L., & Patolsky, F. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00052 · Cited by 25
Kumari, P., Verma, S. K., & Mobin, S. M. (2017) · Chemical Communications · doi:10.1039/c7cc07812a · Cited by 23
Advances in Cell Culture: More than a Century after Cultivating Cells
Souza, A. D. G., & Ferreira, I. C. C. (2016) · Journal of Biotechnology & Biomaterials · doi:10.4172/2155-952x.1000221 · Cited by 24
“[21].”
Application of microfluidic chips in anticancer drug screening
Fan, X., Deng, Z.-F., Yan, Y., Vé, O., Shypko, A., Orel, V. B., Ivanova, D., Pilarsky, C. P., Tang, J. P., Chen, Z., et al. (2021) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6484 · Cited by 27
Khan, A. H., Zhou, S. P., Moe, M., Quesada, B. A. O., Bajgiran, K. R., Lassiter, H. R., Dorman, J. A., Martin, E. C., Pojman, J. A., & Melvin, A. T. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00491 · Cited by 27
Rasmi, C. K., Padmanabhan, S., Shirlekar, K., Rajan, K., Manjithaya, R. R., Singh, V., & Mondal, P. P. (2017) · Applied Physics Letters · doi:10.1063/1.5009782 · Cited by 22
Wang, T., Wang, L., Wang, G., & Zhuang, Y. (2020) · Bioresources and Bioprocessing · doi:10.1186/s40643-020-00325-7 · Cited by 22
Metadata
- Authors
- Patra, B., Peng, C.-C., Liao, W.-H., Lee, C.-H., & Tung, Y.-C.
- Affiliations
- Research Center for Applied Science, Academia Sinica (TW)
- National Taiwan University (TW)
- Corresponding author
- Tung, Yi-Chung
- Venue
- Scientific Reports
- Published
- 2016-02-15
- Volume
- 6
- Issue
- 1
- Pages
- 21061-21061
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4753452
- OpenAlex
- W2418686488
- Semantic Scholar
- 7307a15de169129b35cb9cf7d983952599516694
- Cited by
- 215
- References
- 36
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 20 · 2023: 20 · 2022: 23 · 2021: 29 · 2020: 18 · 2019: 23 · 2018: 24 · 2017: 27 · 2016: 10
- FWCI
- 13.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Academia Sinica
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor spheroids, microfluidics, drug screening, flow cytometry, 3D cell culture, hepatocellular carcinoma, HepG2 cells, cisplatin, resveratrol, tirapazamine, combination therapy, spheroid size, 2D vs 3D cell culture, single-cell analysis
- MeSH terms
- Drug Screening Assays, Antitumor, Flow Cytometry, Humans, Spheroids, Cellular, Cell Culture Techniques, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.